Ardelyx chief development officer sells shares worth 165,743
| ARDX Stock | USD 5.31 0.19 3.71% |
Slightly above 65% of all Ardelyx's investors are looking to take a long position. The analysis of the overall investor sentiment regarding Ardelyx suggests that some traders are interested. Ardelyx's investing sentiment can be driven by a variety of factors including economic data, Ardelyx's earnings reports, geopolitical events, and overall market trends.
Ardelyx |
Ardelyx chief development officer sells shares worth 165,743
Read at investing.com
 |
Ardelyx Current Investor Sentiment
Panic Vs Confidence
65
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Ardelyx's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Ardelyx.
News SentimentBullish | Hype SentimentBullish | Insider SentimentDisposing |
Ardelyx Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Ardelyx can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Ardelyx Fundamental Analysis
We analyze Ardelyx's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ardelyx using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ardelyx based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Cash And Equivalents
Cash And Equivalents Comparative Analysis
Ardelyx is currently under evaluation in cash and equivalents category among its peers. Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Ardelyx Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Ardelyx stock to make a market-neutral strategy. Peer analysis of Ardelyx could also be used in its relative valuation, which is a method of valuing Ardelyx by comparing valuation metrics with similar companies.
Peers
Ardelyx Related Equities
| LXRX | Lexicon Pharmaceuticals | 11.69 | ||||
| MCRB | Seres Therapeutics | 5.48 | ||||
| INZY | Inozyme Pharma | 4.46 | ||||
| VSTM | Verastem | 1.78 | ||||
| TERN | Terns Pharmaceuticals | 1.40 | ||||
| IBRX | Immunitybio | 1.19 | ||||
| MREO | Mereo BioPharma | 1.09 | ||||
| HEPA | Hepion Pharmaceuticals | 4.35 | ||||
| PDSB | PDS Biotechnology | 5.00 | ||||
| HOOK | Hookipa Pharma | 6.52 | ||||
| ZURA | Zura Bio | 6.83 | ||||
| BLRX | BioLineRx | 12.50 |
Additional Tools for Ardelyx Stock Analysis
When running Ardelyx's price analysis, check to measure Ardelyx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ardelyx is operating at the current time. Most of Ardelyx's value examination focuses on studying past and present price action to predict the probability of Ardelyx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ardelyx's price. Additionally, you may evaluate how the addition of Ardelyx to your portfolios can decrease your overall portfolio volatility.